Bristol-Myers Squibb (BMY)

45.52 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (4/25/19)
- M&A (9/30/19 *Est)

Latest Headlines

Form 8-K BRISTOL MYERS SQUIBB CO For: Apr 17 April 17, 2019 8:35 AM - SEC Filing Bristol-Myers Squibb Company Announces Commencement of Exchange Offers and Consent Solicitations for Celgene Notes April 17, 2019 8:18 AM - BizWire Bristol-Myers Squibb Co. (BMY) PT Raised to $63 at BMO Capital April 17, 2019 6:46 AM - StreetInsider Form 8-K BRISTOL MYERS SQUIBB CO For: Apr 12 April 12, 2019 5:28 PM - SEC Filing Bristol-Myers Squibb Shareholders Approve Celgene Acquisition April 12, 2019 10:48 AM - BizWire Celgene (CELG) Stockholders Approve Acquisition by Bristol-Myers Squibb (BMY) April 12, 2019 10:34 AM - StreetInsider Celgene Stockholders Approve Proposed Acquisition by Bristol-Myers Squibb April 12, 2019 10:33 AM - BizWire Celgene (CELG) call put ratio 2.5 calls to 1 put into Bristol-Myers Squibb (BMY) Wins Shareholder Vote on Celgene Takeover April 12, 2019 10:25 AM - StreetInsider Bristol-Myers Squibb (BMY) Wins Shareholder Vote on Celgene (CELG) Takeover - Bloomberg April 12, 2019 10:23 AM - StreetInsider Bristol-Myers Squibb (BMY) is Said to be Poised to Win Celgene (CELG) Deal Vote - Bloomberg April 12, 2019 8:42 AM - StreetInsider Kitov Announces Key Milestone in FameWave Acquisition April 12, 2019 8:29 AM - StreetInsider Kitov Announces Key Milestone in FameWave Acquisition April 12, 2019 8:28 AM - Globe NewsWire FameWave Announces Clinical Collaboration with Bristol Myers Squibb for the Planned Phase 1/2 Trial in Non-Small Cell Lung Cancer to Evaluate Immuno-Oncology Candidate CM-24 in Combination with Nivolu April 12, 2019 7:50 AM - StreetInsider FameWave Announces Clinical Collaboration with Bristol Myers Squibb for the Planned Phase 1/2 Trial in Non-Small Cell Lung Cancer to Evaluate Immuno-Oncology Candidate CM-24 in Combination with Nivolu April 12, 2019 7:49 AM - Globe NewsWire Bristol-Myers Squibb Receives 2019 ENERGY STAR® Partner of the Year – Sustained Excellence Award April 11, 2019 6:59 AM - BizWire Form 4 BRISTOL MYERS SQUIBB CO For: Apr 03 Filed by: Lynch Thomas J. Jr. April 5, 2019 4:33 PM - SEC Filing Form 8-K BRISTOL MYERS SQUIBB CO For: Apr 04 April 4, 2019 4:25 PM - SEC Filing Bristol-Myers Squibb (BMY) option implied volatility flat on expectation for Celgene (CELG) April 3, 2019 11:07 AM - StreetInsider Form 4 BRISTOL MYERS SQUIBB CO For: Mar 31 Filed by: Vousden Karen H April 2, 2019 4:53 PM - SEC Filing Form 4 BRISTOL MYERS SQUIBB CO For: Mar 31 Filed by: Samuels Theodore R. II April 2, 2019 4:52 PM - SEC Filing Form 4 BRISTOL MYERS SQUIBB CO For: Mar 31 Filed by: Storch Gerald L April 2, 2019 4:52 PM - SEC Filing Form 4 BRISTOL MYERS SQUIBB CO For: Mar 31 Filed by: Paliwal Dinesh C April 2, 2019 4:51 PM - SEC Filing Form 4 BRISTOL MYERS SQUIBB CO For: Mar 31 Filed by: LACY ALAN J April 2, 2019 4:50 PM - SEC Filing Form 4 BRISTOL MYERS SQUIBB CO For: Mar 31 Filed by: GROBSTEIN MICHAEL April 2, 2019 4:50 PM - SEC Filing Form 4 BRISTOL MYERS SQUIBB CO For: Mar 31 Filed by: Emmens Matthew April 2, 2019 4:49 PM - SEC Filing Form 4 BRISTOL MYERS SQUIBB CO For: Mar 31 Filed by: BERTOLINI ROBERT J April 2, 2019 4:48 PM - SEC Filing Form 4 BRISTOL MYERS SQUIBB CO For: Mar 31 Filed by: Arduini Peter J April 2, 2019 4:47 PM - SEC Filing Bristol-Myers Squibb (BMY) Announces Long-Term Survival Results from Opdivo in Lung Cancer April 2, 2019 1:03 PM - StreetInsider Bristol-Myers Squibb Announces Long-Term Survival Results from Pooled Analyses of Opdivo (nivolumab) in Previously-Treated Non-Small Cell Lung Cancer Patients April 2, 2019 1:00 PM - BizWire Bristol-Myers Squibb (BMY) option implied volatility flat April 1, 2019 4:54 AM - StreetInsider Novartis to Acquire IFM Tre to Develop First-In-Class NLRP3 Antagonist Portfolio Targeting Innate Immune System April 1, 2019 1:15 AM - PR NewsWire Form DFAN14A BRISTOL MYERS SQUIBB CO Filed by: Starboard Value LP March 29, 2019 4:00 PM - SEC Filing Bristol-Myers Squibb Issues Statement on Celgene’s Settlement with Alvogen on Revlimid® Patent Litigation March 29, 2019 1:33 PM - BizWire Starboard to withdraw its proxy solicitation to vote against the Celgene (CELG)/Bristol-Myers (BMY) deal March 29, 2019 12:03 PM - StreetInsider Starboard Issues Statement on Bristol-Myers March 29, 2019 12:02 PM - PR NewsWire Bristol-Myers Squibb (BMY) puts active after ISS recommends in favor of Celgene (CELG) deal March 29, 2019 11:38 AM - StreetInsider Active options: TSLA BB BMY FB COTY BABA NFLX JD WFC March 29, 2019 11:27 AM - StreetInsider Bristol-Myers Squibb (BMY) Confirms ISS and Glass Lewis Recommend Shareholders Vote for Proposed Merger with Celgene (CELG) March 29, 2019 11:14 AM - StreetInsider Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Bristol-Myers Squibb Shareholders Vote “FOR” Proposed Merger with Celgene March 29, 2019 11:13 AM - BizWire Celgene (CELG)/Bristol-Myers Squibb (BMY) Deal Spread Collapses to 4.1% March 29, 2019 10:19 AM - StreetInsider Glass Lewis Recommends Bristol-Myers Squibb (BMY) Holders Vote for Celgene (CELG) Deal - Bloomberg March 29, 2019 9:51 AM - StreetInsider Bristol-Myers Squibb (BMY) option implied volatility flat into ISS recommends in favor of Celgene (CELG) deal March 29, 2019 9:30 AM - StreetInsider Pre-Open Stock Movers 03/29: (BOXL) (PRGS) (CELG) Higher; (SGH) (RH) (CHMA) Lower (more...) March 29, 2019 9:27 AM - StreetInsider ISS Recommends Shareholders Vote 'FOR' Bristol-Myers Squibb (BMY)/Celgene (CELG) Deal March 29, 2019 9:17 AM - StreetInsider ISS Recommends Bristol-Myers Squibb (BMY) Holders Vote for Celgene (CELG) Deal - CNBC March 29, 2019 9:10 AM - StreetInsider Celgene (CELG) Shares Spike 6% March 29, 2019 9:02 AM - StreetInsider Active options: LULU AMZN GE PBR DB MU BMY BA MSFT T NFLX NLSN March 29, 2019 4:41 AM - StreetInsider Form DFAN14A BRISTOL MYERS SQUIBB CO Filed by: Starboard Value LP March 28, 2019 5:01 PM - SEC Filing Celgene (CELG) Drifts to Low, Down 2.5% March 28, 2019 3:04 PM - StreetInsider Starboard Mails Letter to All Bristol-Myers Squibb Shareholders March 28, 2019 10:07 AM - PR NewsWire IFM Therapeutics Announces Dosing of First Subjects in Phase 1 Healthy Volunteer Study of Lead NLRP3 Antagonist, IFM-2427 March 28, 2019 7:00 AM - PR NewsWire Bristol-Myers Squibb Co. (BMY) PT Raised to $68 at Societe Generale March 27, 2019 1:23 PM - StreetInsider Bristol-Myers Squibb (BMY) April calls active into ISS expected to weigh in on Celgene deal soon March 27, 2019 10:31 AM - StreetInsider Celgene (CELG) April puts active into ISS expected to weigh in on the Bristol-Myers Squibb (BMY)/Celgene (CELG) deal March 27, 2019 10:27 AM - StreetInsider ISS Seen Weighing in on Celgene (CELG)/Bristol-Myers Squibb (BMY) Deal on Monday - Faber March 27, 2019 10:08 AM - StreetInsider Bristol-Myers Squibb (BMY) Receives FTC Second Request in Connection with Celgene (CELG) Deal March 26, 2019 7:10 AM - StreetInsider Form 8-K BRISTOL MYERS SQUIBB CO For: Mar 25 March 26, 2019 7:05 AM - SEC Filing Bristol-Myers Squibb (BMY) Board Provides Open Letter Shareholder Regarding Merger Agreement with Celgene Corp. (CELG) March 25, 2019 7:02 AM - StreetInsider Bristol-Myers Squibb Board of Directors Sends Letter to Shareholders Highlighting the Compelling Strategic and Financial Rationale of the Celgene Transaction; Company Provides Additional Investor Mate March 25, 2019 6:59 AM - BizWire Form DFAN14A BRISTOL MYERS SQUIBB CO Filed by: Starboard Value LP March 22, 2019 5:22 PM - SEC Filing Starboard's Smith Says He is not Short Celgene (CELG) - CNBC March 22, 2019 10:32 AM - StreetInsider Bristol-Myers Squibb (BMY) Deal for Celgene (CELG) Will Likely Go Through - Barclays March 22, 2019 9:33 AM - StreetInsider Bristol-Myers Squibb (BMY) PT Raised At BMO On Combination With Celgene March 20, 2019 6:51 AM - StreetInsider Form DFAN14A BRISTOL MYERS SQUIBB CO Filed by: Starboard Value LP March 19, 2019 4:58 PM - SEC Filing No Smoking Gun from Starboard on Bristol-Myers (BMY)/Celgene (CELG) Deal; Sees ISS in Favor - Jefferies March 19, 2019 11:45 AM - StreetInsider Starboard Issues Investor Presentation Opposing Bristol-Myers Squibb's (BMY) Ill-Advised Proposed Acquisition of Celgene (CELG) March 19, 2019 7:04 AM - StreetInsider Starboard Issues Investor Presentation Opposing Bristol-Myers Squibb's Ill-Advised Proposed Acquisition of Celgene March 19, 2019 7:00 AM - PR NewsWire Bristol-Myers Squibb (BMY) Highlights Significant Benefits of Pending Transaction with Celgene (CELG) March 19, 2019 7:00 AM - StreetInsider Bristol-Myers Squibb Files Investor Presentation Highlighting Significant Benefits of Pending Transaction with Celgene March 19, 2019 6:59 AM - BizWire Form DFAN14A BRISTOL MYERS SQUIBB CO Filed by: Starboard Value LP March 18, 2019 5:31 PM - SEC Filing Bristol-Myers Squibb (BMY) option implied volatility increases March 18, 2019 4:50 AM - StreetInsider AUGUSTUS Demonstrates Favorable Safety Results of Eliquis® Versus Vitamin K Antagonists in Non-Valvular Atrial Fibrillation Patients with Acute Coronary Syndrome and/or Undergoing Percutaneous Corona March 17, 2019 11:45 AM - BizWire Form DEFC14A BRISTOL MYERS SQUIBB CO Filed by: Starboard Value LP March 15, 2019 12:34 PM - SEC Filing Active options: BMY ADBE AVGO AMD BAC F MU MSFT NIO NFLX LRCX March 15, 2019 9:42 AM - StreetInsider Popular stocks with increasing unusual: BMY CELG NIO COTY SNAP March 15, 2019 5:09 AM - StreetInsider Stocks with Implied Volatility Movement March 15, 2019 4:47 AM - StreetInsider Bristol-Myers Squibb (BMY) options active as shares sell off 3.8% March 14, 2019 11:07 AM - StreetInsider Bristol-Myers Squibb (BMY)/Celgene (CELG) Merger Spread Continues to Narrow March 14, 2019 11:03 AM - StreetInsider Bristol-Myers Squibb (BMY) Trades at Low, Down 3.4% March 14, 2019 10:56 AM - StreetInsider Celgene (CELG) Revlimid Patent Escapes IPR Review Sought by Alvogen - Bloomberg March 14, 2019 7:59 AM - StreetInsider Stocks with Implied Volatility Movement March 14, 2019 4:52 AM - StreetInsider Celgene (CELG), Bristol-Myers Squibb (BMY) Both Gain as Deal Spread Shrinks March 13, 2019 12:52 PM - StreetInsider Form 4 BRISTOL MYERS SQUIBB CO For: Mar 10 Filed by: Elicker John E March 13, 2019 7:43 AM - SEC Filing Form 4 BRISTOL MYERS SQUIBB CO For: Mar 10 Filed by: Dubow Adam March 13, 2019 7:42 AM - SEC Filing Form 4 BRISTOL MYERS SQUIBB CO For: Mar 10 Filed by: BOERNER CHRISTOPHER S. March 13, 2019 7:42 AM - SEC Filing Form 4 BRISTOL MYERS SQUIBB CO For: Mar 10 Filed by: Caforio Giovanni March 13, 2019 7:41 AM - SEC Filing Form 4 BRISTOL MYERS SQUIBB CO For: Mar 10 Filed by: Biondi Paul March 13, 2019 7:40 AM - SEC Filing Form 4 BRISTOL MYERS SQUIBB CO For: Mar 10 Filed by: Bancroft Charles A March 13, 2019 7:40 AM - SEC Filing Form 4 BRISTOL MYERS SQUIBB CO For: Mar 10 Filed by: von Autenried Paul March 13, 2019 7:39 AM - SEC Filing Form 4 BRISTOL MYERS SQUIBB CO For: Mar 10 Filed by: Schmukler Louis S March 13, 2019 7:39 AM - SEC Filing Form 4 BRISTOL MYERS SQUIBB CO For: Mar 10 Filed by: Santiago Karen Murphy March 13, 2019 7:38 AM - SEC Filing Form 4 BRISTOL MYERS SQUIBB CO For: Mar 10 Filed by: Lynch Thomas J. Jr. March 13, 2019 7:37 AM - SEC Filing Form 4 BRISTOL MYERS SQUIBB CO For: Mar 10 Filed by: LEUNG SANDRA March 13, 2019 7:36 AM - SEC Filing Form 4 BRISTOL MYERS SQUIBB CO For: Mar 10 Filed by: JUDGE ANN POWELL March 13, 2019 7:35 AM - SEC Filing Form PRRN14A BRISTOL MYERS SQUIBB CO Filed by: Starboard Value LP March 13, 2019 6:05 AM - SEC Filing Bristol-Myers' (BMY) Lack of Suitor Positive for Celgene (CELG) Deal - Baird March 12, 2019 1:34 PM - StreetInsider Bristol-Myers (BMY) Had Informal, High Level Past Deal Talks with Others; Past Talks Had no Terms, were Informal, no Offers - Bloomberg, Citing CEO March 12, 2019 11:54 AM - StreetInsider Third Point, DE Shaw Not Involved with Celgene (CELG)/Bristol-Myers (BMY) - CNBC March 12, 2019 9:49 AM - StreetInsider Biocartis Group NV: Biocartis and Bristol-Myers Squibb Sign Collaboration Agreement for MSI Testing with Immuno-Oncology Therapies March 12, 2019 2:02 AM - StreetInsider Biocartis Group NV: Biocartis and Bristol-Myers Squibb Sign Collaboration Agreement for MSI Testing with Immuno-Oncology Therapies March 12, 2019 2:01 AM - StreetInsider Form 8-K BRISTOL MYERS SQUIBB CO For: Mar 08 March 8, 2019 7:07 AM - SEC Filing Form 8-K BRISTOL MYERS SQUIBB CO For: Mar 08 March 8, 2019 7:03 AM - SEC Filing Bristol-Myers Squibb (BMY) Declares $0.41 Quarterly Dividend; 3.2% Yield March 7, 2019 5:22 PM - StreetInsider Bristol-Myers Squibb Announces Dividend March 7, 2019 5:22 PM - BizWire Bristol-Myers Squibb to Announce Results for First Quarter 2019 on April 25, 2019 March 7, 2019 6:59 AM - BizWire Stocks with Implied Volatility Movement March 7, 2019 5:20 AM - StreetInsider Form DFAN14A BRISTOL MYERS SQUIBB CO Filed by: Starboard Value LP March 6, 2019 5:17 PM - SEC Filing Bristol-Myers Squibb to Take Part in the Barclays 2019 Global Healthcare Conference March 6, 2019 4:58 PM - BizWire Starboard Mails Letter to All Bristol-Myers Squibb (BMY) Stockholders March 6, 2019 7:39 AM - StreetInsider Starboard Mails Letter with Important Message to All Bristol-Myers Squibb Stockholders March 6, 2019 7:31 AM - PR NewsWire Bristol-Myers Squibb (BMY) Files Investor Presentation, Letter From Board Related to Pending Celgene (CELG) Deal March 6, 2019 7:10 AM - StreetInsider Bristol-Myers Squibb Files Investor Presentation and Board of Directors Sends Letter to Shareholders Regarding Pending Transaction with Celgene March 6, 2019 6:59 AM - BizWire Bristol-Myers Squibb to Take Part in the Cowen and Company 39th Annual Health Care Conference March 5, 2019 6:59 AM - BizWire Stocks with Implied Volatility Movement March 5, 2019 5:21 AM - StreetInsider Form 4 BRISTOL MYERS SQUIBB CO For: Feb 28 Filed by: LEUNG SANDRA March 4, 2019 4:44 PM - SEC Filing Form 4 BRISTOL MYERS SQUIBB CO For: Feb 28 Filed by: Bancroft Charles A March 4, 2019 4:44 PM - SEC Filing Form PREC14A BRISTOL MYERS SQUIBB CO Filed by: Starboard Value LP March 1, 2019 5:02 PM - SEC Filing Form DFAN14A BRISTOL MYERS SQUIBB CO Filed by: Starboard Value LP February 28, 2019 5:09 PM - SEC Filing Bristol-Myers Squibb (BMY) Responded to Starboard's Letter, Confident in Combination with Celgene (CELG) February 28, 2019 12:00 PM - StreetInsider Bristol-Myers Squibb Issues Statement in Response to Starboard’s Letter February 28, 2019 11:59 AM - BizWire Starboard Value says Bristol-Myers Squibb's (BMY) proposed merger with Celgene (CELG) is ill-advised February 28, 2019 9:42 AM - StreetInsider Starboard Delivers Open Letter to Bristol-Myers Squibb Stockholders February 28, 2019 9:40 AM - PR NewsWire Options expected to have increasing volume: SQ BKNG BUD CELG BMY BUD JCP February 28, 2019 9:08 AM - StreetInsider Bristol-Myers Squibb (BMY) call put ratio 1 call to 1.1 put into Wellington says it does not support Bristol-Myers' acquisition of Celgene February 28, 2019 6:00 AM - StreetInsider Bristol-Myers Squibb (BMY) IV into Wellington says it does not support Bristol-Myers' acquisition of Celgene (CELG) February 28, 2019 5:55 AM - StreetInsider After-Hours Movers 02/27: (TTOO) (TWNK) (WBC) Higher; (BOX) (BKNG) (CELG) (more...) February 27, 2019 5:33 PM - StreetInsider Form SC 13D BRISTOL MYERS SQUIBB CO Filed by: WELLINGTON MANAGEMENT GROUP LLP February 27, 2019 5:28 PM - SEC Filing Wellington Management Says it Does Not Support Bristol-Myers Squibb's (BMY) Acquisition of Celgene (CELG) February 27, 2019 4:27 PM - StreetInsider Wellington Management Does Not Support Bristol-Myers Squibb’s Acquisition of Celgene Corporation February 27, 2019 4:22 PM - BizWire Grassley, Wyden Deliver Opening Remarks in Drug Pricing Hearing - Bloomberg February 26, 2019 10:40 AM - StreetInsider Form 10-K BRISTOL MYERS SQUIBB CO For: Dec 31 February 25, 2019 4:55 PM - SEC Filing Form EFFECT BRISTOL MYERS SQUIBB CO February 25, 2019 6:02 AM - SEC Filing Bristol-Myers Squibb Announces Filing of Definitive Proxy Statement in Connection with Proposed Merger with Celgene February 22, 2019 4:49 PM - BizWire Form 424B3 BRISTOL MYERS SQUIBB CO February 22, 2019 4:34 PM - SEC Filing Bristol-Myers Squibb (BMY) call put ratio 2.2 calls to 1 put with focus on February weekly 52 calls February 21, 2019 9:47 AM - StreetInsider Bristol-Myers Squibb (BMY) on Watch Amid Chatter February 21, 2019 9:45 AM - StreetInsider Starboard Unhappy with Bristol-Myers Squibb (BMY) Deal to Buy Celgene (CELG); Dodge & Cox Also Unhappy - WSJ February 20, 2019 2:26 PM - StreetInsider Bristol-Myers Squibb (BMY) said Starboard Value informed it that it has acquired 1M shares; Proposed 5 to board February 20, 2019 9:41 AM - StreetInsider Form S-4/A BRISTOL MYERS SQUIBB CO February 20, 2019 9:20 AM - SEC Filing Bristol-Myers Squibb (BMY) Provides Update on Pending Transaction with Celgene (CELG), Says Remains on Track to Close in Q3 February 20, 2019 9:02 AM - StreetInsider Bristol-Myers Squibb Provides Update on Pending Transaction with Celgene February 20, 2019 9:00 AM - BizWire Bristol-Myers Squibb (BMY) PT Cut To $59 At BMO On Reduced Opdivo Opportunity February 19, 2019 8:50 AM - StreetInsider Bristol-Myers Squibb Co. (BMY) PT Lowered to $51 at BofA/Merrill Lynch February 19, 2019 6:33 AM - StreetInsider Bristol-Myers Squibb (BMY) Reports Opdivo (nivolumab) Plus Yervoy (ipilimumab) Shows Response in Pre-Treated Patients with Metastatic Castration-Resistant Prostate Cancer February 14, 2019 5:00 PM - StreetInsider Active options: FB NFLX BMY AMZN TSLA INTC CTL BABA MSFT EA ATVI February 14, 2019 4:04 PM - StreetInsider Opdivo (nivolumab) Plus Yervoy (ipilimumab) Shows Response in Pre-Treated Patients with Metastatic Castration-Resistant Prostate Cancer February 14, 2019 4:00 PM - BizWire Bristol-Myers Squibb Co. (BMY) PT Raised to $55 at UBS February 14, 2019 6:07 AM - StreetInsider Form 4/A BRISTOL MYERS SQUIBB CO For: Apr 30 Filed by: Paliwal Dinesh C February 13, 2019 4:45 PM - SEC Filing Form SC 13G/A BRISTOL MYERS SQUIBB CO Filed by: WELLINGTON MANAGEMENT GROUP LLP February 12, 2019 9:47 AM - SEC Filing Bristol-Myers Squibb (BMY) Announces Opdivo Plus Low-Dose Yervoy Demonstrates Continued Survival Benefit at 30-Month Follow-up in Patients with Previously Untreated Advanced or Metastatic RCC February 11, 2019 5:05 PM - StreetInsider Opdivo (nivolumab) Plus Low-Dose Yervoy (ipilimumab) Demonstrates Continued Survival Benefit at 30-Month Follow-up in Patients with Previously Untreated Advanced or Metastatic Renal Cell Carcinoma February 11, 2019 5:00 PM - BizWire Celgene (CELG)/Bristol-Myers (BMY) Deal Probably Goes Up on Patent Ruling - SVB Lerrink February 11, 2019 2:01 PM - StreetInsider Form SC 13G/A BRISTOL MYERS SQUIBB CO Filed by: VANGUARD GROUP INC February 11, 2019 8:05 AM - SEC Filing Bristol-Myers Squibb (BMY) Announces EC Approval for its Sprycel in Combination with Chemotherapy for Treatment of Pediatric Patients with Newly Diagnosed Ph+ ALL February 11, 2019 7:00 AM - StreetInsider European Commission Approves Bristol-Myers Squibb’s Sprycel (dasatinib) in Combination with Chemotherapy for Treatment of Pediatric Patients with Newly Diagnosed Philadelphia Chromosome-Positive Acu February 11, 2019 6:59 AM - BizWire Bristol-Myers Squibb to Take Part in Guggenheim Healthcare Talks Idea Forum February 7, 2019 6:59 AM - BizWire Form 4 BRISTOL MYERS SQUIBB CO For: Feb 01 Filed by: Arduini Peter J February 5, 2019 4:55 PM - SEC Filing Form 4 BRISTOL MYERS SQUIBB CO For: Feb 02 Filed by: BOERNER CHRISTOPHER S. February 5, 2019 4:54 PM - SEC Filing Form 4 BRISTOL MYERS SQUIBB CO For: Feb 01 Filed by: Vousden Karen H February 5, 2019 4:52 PM - SEC Filing Form 4 BRISTOL MYERS SQUIBB CO For: Feb 01 Filed by: Storch Gerald L February 5, 2019 4:52 PM - SEC Filing Form 4 BRISTOL MYERS SQUIBB CO For: Feb 01 Filed by: SATO VICKI L February 5, 2019 4:51 PM - SEC Filing Form 4 BRISTOL MYERS SQUIBB CO For: Feb 01 Filed by: Samuels Theodore R. II February 5, 2019 4:50 PM - SEC Filing Form 4 BRISTOL MYERS SQUIBB CO For: Feb 01 Filed by: Paliwal Dinesh C February 5, 2019 4:49 PM - SEC Filing Form 4 BRISTOL MYERS SQUIBB CO For: Feb 01 Filed by: LACY ALAN J February 5, 2019 4:49 PM - SEC Filing Form 4 BRISTOL MYERS SQUIBB CO For: Feb 01 Filed by: GROBSTEIN MICHAEL February 5, 2019 4:48 PM - SEC Filing Form 4 BRISTOL MYERS SQUIBB CO For: Feb 01 Filed by: Emmens Matthew February 5, 2019 4:48 PM - SEC Filing Form 4 BRISTOL MYERS SQUIBB CO For: Feb 01 Filed by: BERTOLINI ROBERT J February 5, 2019 4:47 PM - SEC Filing UPDATE: Starboard's Smith Says is Definitely Interested in Bristol-Myers Squibb (BMY), Declines to Say If He Nominated for Board - CNBC February 5, 2019 10:28 AM - StreetInsider Form SC 13G/A BRISTOL MYERS SQUIBB CO Filed by: BlackRock Inc. February 4, 2019 10:13 AM - SEC Filing Bristol-Myers Squibb (BMY) Hasn't Heard from Starboard, CNBC's Faber February 4, 2019 9:39 AM - StreetInsider Starboard Value Said to Take Stake in Bristol-Myers Squibb (BMY) - Bloomberg (Earlier) February 4, 2019 6:25 AM - StreetInsider Bristol-Myers Squibb (BMY) option implied volatility flat into President Trump State of Union Address February 4, 2019 6:15 AM - StreetInsider Form S-4/A BRISTOL MYERS SQUIBB CO February 1, 2019 5:03 PM - SEC Filing Form S-4 BRISTOL MYERS SQUIBB CO February 1, 2019 7:03 AM - SEC Filing Form 4/A BRISTOL MYERS SQUIBB CO For: Dec 02 Filed by: Bancroft Charles A January 31, 2019 4:43 PM - SEC Filing Form 8-K BRISTOL MYERS SQUIBB CO For: Jan 25 January 30, 2019 4:46 PM - SEC Filing BMO Capital Reiterates Outperform on Bristol-Myers Squibb (BMY) January 25, 2019 8:45 AM - StreetInsider Bristol-Myers Squibb Co. (BMY) PT Raised to $53 at BofA/Merrill Lynch January 25, 2019 6:07 AM - StreetInsider Active options: BAC SQ SBUX F QCOM BMY FCX BABA PCG AMZN MSFT January 25, 2019 5:03 AM - StreetInsider Canaccord Genuity Sees Bristol-Myers Acquiring Control of bb2121 from bluebird bio (BLUE) January 24, 2019 10:32 AM - StreetInsider Form 8-K BRISTOL MYERS SQUIBB CO For: Jan 24 January 24, 2019 8:55 AM - SEC Filing Bristol-Myers Squibb (BMY) Tops Q4 EPS by 9c, Offers FY19 Guidance January 24, 2019 7:00 AM - StreetInsider Bristol-Myers Squibb Reports Fourth Quarter and Full Year Financial Results January 24, 2019 6:59 AM - BizWire Bristol-Myers Squibb Announces Time Change for Q4 Earnings Results Conference Call January 24, 2019 6:59 AM - BizWire Popular stocks with increasing volume: BMY PG CSCO INTC QCOM January 24, 2019 4:55 AM - StreetInsider Popular stocks with increasing volume: SBUX BMY FCAU F ARNC BBT IBM January 23, 2019 5:25 AM - StreetInsider Form 8-K BRISTOL MYERS SQUIBB CO For: Jan 18 January 22, 2019 4:38 PM - SEC Filing John Paulson Sees 10%-20% Chance of Bristol (BMY) Takeout, Pauslon Discusses Celgene (CELG)-Bristol Positioning in Podcast - Bloomberg January 22, 2019 8:00 AM - StreetInsider Stocks with Implied Volatility Movement January 22, 2019 5:06 AM - StreetInsider Full Article List